Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$166.16 - $213.96 $20,437 - $26,317
-123 Reduced 82.55%
26 $5,000
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $27,463 - $32,195
149 New
149 $32,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sageworth Trust CO Of South Dakota Portfolio

Follow Sageworth Trust CO Of South Dakota and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.